Persistent AsthmaASMAVIENCT01078688
Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma
An observational study of Persistent Asthma, run by AstraZeneca at 724 sites in France.
Trial summary
Evaluation of the frequency of limitation of activity, depending on gender and age-group, in patients with persistent asthma consulting a general practitioner Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Persistent Asthma
- How many people
- 1,942 participants
- Where
- 724 sitesFrance
- Study dates
- Mar 2010to Oct 2010
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: First 3 consecutive patients with persistent asthma seen by general practitioner receiving long-term maintenance treatment with inhaled steroids
Who may be able to join
- persistent asthma receiving long-term maintenance treatment with inhaled steroids (alone or in combination with other drugs)
Who cannot join
- Patients with a diagnosis of COPD
Trial locations and contacts
724 sites in 1 country.
300 sites in 1 country
France300 sites
Research Site
Abbaretz
Research Site
Abbeville
Research Site
Achenheim
Research Site
Achicourt
Research Site
Afa
Research Site
Aiguillon
Research Site
Aixe-sur-Vienne
Research Site
Ajaccio
Research Site
Albertville
Research Site
Albi
Research Site
Ambès
Research Site
Ambierle
Research Site
Andance
Research Site
Andernos-les-Bains
Research Site
Andrézieux-Bouthéon
Research Site
Anglet
Research Site
Angoulême
Research Site
Anizy-le-Château
Research Site
Annonay
Research Site
Arches
Research Site
Aregno
Research Site
Arles
Research Site
Ars
Research Site
Art-sur-Meurthe
Research Site
Asnières-sur-Seine
Research Site
Aubenas
Research Site
Aubervilliers
Research Site
Auch
Research Site
Auchel
Research Site
Auchy-les-Mines
Research Site
Audincourt
Research Site
Audruicq
Research Site
Aulnat
Research Site
Aulnay-sous-Bois
Research Site
Aurillac
Research Site
Autun
Research Site
Auxi-le-Château
Research Site
Avesnes-le-Sec
Research Site
Bâgé-le-Châtel
Research Site
Bagnères-de-Bigorre
Research Site
Bagneux
Research Site
Baignes Ste Radegonde
Research Site
Bailly
Research Site
Balma
Research Site
Barbezieux-Saint-Hilaire
Research Site
Basse-Goulaine
Research Site
Bassillac
Research Site
Bastia
Research Site
Bayonne
Research Site
Beaumesnil
Research Site
Beaumont-en-Véron
Research Site
Beauzelle
Research Site
Bélâbre
Research Site
Belfort
Research Site
Bellac
Research Site
Belleville-sur-Meuse
Research Site
Belz
Research Site
Bérat
Research Site
Bergholtz
Research Site
Bernin
Research Site
Bétaille
Research Site
Béthune
Research Site
Béville-le-Comte
Research Site
Beynes
Research Site
Béziers
Research Site
Bezons
Research Site
Biganos
Research Site
Bignan
Research Site
Billy-Montigny
Research Site
Blangy-sur-Bresle
Research Site
Blanquefort
Research Site
Blanzat
Research Site
Blénod-lès-Pont-à-Mousson
Research Site
Blois
Research Site
Bobigny
Research Site
Boën-sur-Lignon
Research Site
Bois de Nefles Saint Paul
Research Site
Bois-le-Roi
Research Site
Boiscommun
Research Site
Bompas
Research Site
Bondues
Research Site
Bonsecours
Research Site
Boos
Research Site
Boujan-sur-Libron
Research Site
Boulogne-Billancourt
Research Site
Boulogne-sur-Mer
Research Site
Bourbriac
Research Site
Bourg de Joué-sur-Erdre
Research Site
Bourg-Achard
Research Site
Bourg-de-Péage
Research Site
Bourg-en-Bresse
Research Site
Bourron-Marlotte
Research Site
Bourth
Research Site
Bousse
Research Site
Bréhal
Research Site
Brest
Research Site
Breteuil
Research Site
Breuil-le-Sec
Research Site
Briançon
Research Site
Brie
Research Site
Brienne-le-Château
Research Site
Brive-la-Gaillarde
Research Site
Bruay-la-Buissière
Research Site
Cabannes
Research Site
Caen
Research Site
Callian
Research Site
Caluire-et-Cuire
Research Site
Camors
Research Site
Cannes La Bocca
Research Site
Canteleu
Research Site
Capbreton
Research Site
Carantec
Research Site
Carbon-Blanc
Research Site
Carhaix-Plouguer
Research Site
Carmaux
Research Site
Carnon-Plage
Research Site
Carquefou
Research Site
Carresse-Cassaber
Research Site
Carros
Research Site
Castets-en-Dorthe
Research Site
Castres
Research Site
Cauchy-à-la-Tour
Research Site
Caussade
Research Site
Cavaillon
Research Site
Celles-sur-Plaine
Research Site
Cérences
Research Site
Cernay
Research Site
Châbons
Research Site
Chaillevette
Research Site
Chalais
Research Site
Chalamont
Research Site
Chambéry
Research Site
Chambray-lès-Tours
Research Site
Champagne-sur-Oise
Research Site
Champagnole
Research Site
Champigné
Research Site
Champigny-sur-Marne
Research Site
Chanac
Research Site
Chapelle Saint Martin Plaine
Research Site
Charleville-Mézières
Research Site
Charvieu-Chavagneux
Research Site
Chassieu
Research Site
Château-d'Olonne
Research Site
Château-Thierry
Research Site
Châteaubriant
Research Site
Châteaugay
Research Site
Châteauneuf-en-Thymerais
Research Site
Châtillon-Coligny
Research Site
Châtillon-Saint-Jean
Research Site
Châtillon-sur-Colmont
Research Site
Châtillon-sur-Seine
Research Site
Chauvigny
Research Site
Chavanges
Research Site
Chelles
Research Site
Chenôve
Research Site
Cherves-Richemont
Research Site
Choisey
Research Site
Ciboure
Research Site
Clairac
Research Site
Clamart
Research Site
Clermont-Ferrand
Research Site
Clichy
Research Site
Clichy-sous-Bois
Research Site
Colombes
Research Site
Combrit
Research Site
Comines
Research Site
Commentry
Research Site
Concarneau
Research Site
Conty
Research Site
Corbehem
Research Site
Cordes-sur-Ciel
Research Site
Corseul
Research Site
Coudekerque-Branche
Research Site
Couhé
Research Site
Coulommiers
Research Site
Courcy
Research Site
Coursan
Research Site
Coussac-Bonneval
Research Site
Coye-la-Forêt
Research Site
Créteil
Research Site
Criquetot-l'Esneval
Research Site
Crolles
Research Site
Cugnaux
Research Site
Cuise-la-Motte
Research Site
Culoz
Research Site
Dambach-la-Ville
Research Site
Danjoutin
Research Site
Dessenheim
Research Site
Dieppe
Research Site
Dijon
Research Site
Domène
Research Site
Drancy
Research Site
Drap
Research Site
Dunkirk
Research Site
Ecques
Research Site
Einville-au-Jard
Research Site
Enghien-les-Bains
Research Site
Entre Deux
Research Site
Épernon
Research Site
Équeurdreville-Hainneville
Research Site
Esquerdes
Research Site
Eu
Research Site
Eygalières
Research Site
Eyragues
Research Site
Feurs
Research Site
Firmi
Research Site
Firminy
Research Site
Fitilieu
Research Site
Fitz-James
Research Site
Flers
Research Site
Fleury-les-Aubrais
Research Site
Fleury-sur-Andelle
Research Site
Fléville-devant-Nancy
Research Site
Florange
Research Site
Folembray
Research Site
Fontaine
Research Site
Fos-sur-Mer
Research Site
Fougères
Research Site
Fouras
Research Site
Fourchambault
Research Site
Frontenas
Research Site
Frotey-lès-Vesoul
Research Site
Gaillon
Research Site
Gallardon
Research Site
Gardonne
Research Site
Garéoult
Research Site
Gauriac
Research Site
Gelles
Research Site
Gelos
Research Site
Gennes
Research Site
Gennevilliers
Research Site
Gignac-la-Nerthe
Research Site
Givors
Research Site
Gondrecourt-le-Château
Research Site
Gonneville-la-Mallet
Research Site
Gorron
Research Site
Goudelin
Research Site
Gourdon
Research Site
Grand-Bois
Research Site
Grane
Research Site
Granville
Research Site
Graulhet
Research Site
Grignols
Research Site
Guenrouet
Research Site
Guéret
Research Site
Guignicourt
Research Site
Guise
Research Site
Guitalens-L'Albarède
Research Site
Hagondange
Research Site
Ham
Research Site
Hanvec
Research Site
Hénin-Beaumont
Research Site
Houilles
Research Site
Hulluch
Research Site
Hundling
Research Site
Inchy
Research Site
Isle
Research Site
Issy-les-Moulineaux
Research Site
Istres
Research Site
Ivry-sur-Seine
Research Site
Jacou
Research Site
Jargeau
Research Site
Jarville-la-Malgrange
Research Site
Jassans-Riottier
Research Site
Joncherey
Research Site
Jonquières-Saint-Vincent
Research Site
Jouy-le-Châtel
Research Site
Jugon-les-Lacs
Research Site
Jussey
Research Site
Knutange
Research Site
L Etang Sale
Research Site
L'Haÿ-les-Roses
Research Site
L'Isle-Jourdain
Research Site
La Bâtie-Neuve
Research Site
La Baule-Escoublac
Research Site
La Bretagne
Research Site
La Broque
Research Site
La Cambe
Research Site
La Chapelle-des-Marais
Research Site
La Chapelle-en-Serval
Research Site
La Courneuve
Research Site
La Fère
Research Site
La Ferté-Saint-Aubin
Research Site
La Forêt-sur-Sèvre
Research Site
La Fouillade
Research Site
La Francheville
Research Site
La Garde
Research Site
La Garenne-Colombes
Research Site
La Haye-Pesnel
Research Site
La Madeleine
Research Site
La Mothe-Saint-Héray
Research Site
La Motte-Servolex
Research Site
La Seyne-sur-Mer
Research Site
La Talaudière
Research Site
La Teste-de-Buch
Research Site
La Tour-de-Salvagny
Research Site
La Varenne-Saint-Hilaire
Research Site
Labarthe-sur-Lèze
Research Site
Labenne
Research Site
Lagarde-Enval
About this study
Official title: Evaluation of the Frequency of Limitation of Activity, Depending on Gender and Age-group, in Patients With Persistent Asthma Consulting a General Practitioner
Evaluation of the frequency of limitation of activity, depending on gender and age-group, in patients with persistent asthma consulting a general practitioner
- Conditions
- Persistent Asthma
- Keywords
- Limitations of activities, persistent asthma, general practitioner, frequency of limitations of activities, depending on gender and age-group
What is being measured
The primary outcome is the main question the study is designed to answer.
To describe the frequency of limitations of activities in patients with persistent asthma depending on gender and age-group.
Measured: Last 3 months / once
To describe, depending on gender and age-group, the nature of the activities limited, the degree of limitation and the impact on the patient's daily life.
Measured: Once during only visit
Secondary outcomes (3)
To describe the nature of the activities limited, the degree of limitation and the impact on the patient's daily life according to the level of asthma control
Measured: Once during only visit
To describe, depending on gender and age-group, the activities that need to be specifically investigated in routine clinical practice due to their greater impact on the patient's quality of life, and which could indicate poorly controlled asthma
Measured: Once during only visit
To describe the main characteristics and initial management for all patients of the survey
Measured: Once during only visit
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Mar 2010 (estimated)
- Study startMar 2010
- Primary completionOct 2010
- Study completionOct 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Persistent AsthmaStudies of the same condition, open and under way.
- More trials run by AstraZenecaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 1,942 participants (actual)
Sponsor and investigators
- Lead sponsor
- AstraZeneca
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Pascal Piedbois, Study director, AstraZeneca
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01078688
- Sponsor's protocol ID
- NIS-RFR-DUM-2009/2
- Acronym
- ASMAVIE
- Status last verified
- Jan 2013
- First submitted
- 25 Feb 2010
- Last updated
- 29 Jan 2013
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Jan 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of the Frequency of Limitation of Activity, Depending on Gender and Age-group, in Patients With Persistent Asthma Consulting a General Practitioner
- ClinicalTrials.gov ID
- NCT01078688
- Acronym / sponsor ID
- ASMAVIE / NIS-RFR-DUM-2009/2
- Conditions
- Persistent Asthma
- Keywords
- Limitations of activities, persistent asthma, general practitioner, frequency of limitations of activities, depending on gender and age-group
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,942 participants (actual)
- Lead sponsor
- AstraZenecaIndustry (pharma, biotech, devices)
- Study start
- Mar 2010
- Primary completion
- Oct 2010 (actual)
- Study completion
- Oct 2010 (actual)
- First posted
- 2 Mar 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evaluation of the frequency of limitation of activity, depending on gender and age-group, in patients with persistent asthma consulting a general practitioner
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- First 3 consecutive patients with persistent asthma seen by general practitioner receiving long-term maintenance treatment with inhaled steroids
Key inclusion criteria (1 listed)
- persistent asthma receiving long-term maintenance treatment with inhaled steroids (alone or in combination with other drugs)
Key exclusion criteria (1 listed)
- Patients with a diagnosis of COPD
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
To describe the frequency of limitations of activities in patients with persistent asthma depending on gender and age-group.
Time frame: Last 3 months / once
To describe, depending on gender and age-group, the nature of the activities limited, the degree of limitation and the impact on the patient's daily life.
Time frame: Once during only visit
3 secondary outcomes
To describe the nature of the activities limited, the degree of limitation and the impact on the patient's daily life according to the level of asthma control
Time frame: Once during only visit
To describe, depending on gender and age-group, the activities that need to be specifically investigated in routine clinical practice due to their greater impact on the patient's quality of life, and which could indicate poorly controlled asthma
Time frame: Once during only visit
To describe the main characteristics and initial management for all patients of the survey
Time frame: Once during only visit
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jan 2013.
Related trials for Persistent Asthma
Recruiting
THERMotherapy Against Persistent Bacterial LUNG Infections
Lung Diseases, Obstructive, Bronchiectasis
RecruitingObservational study
Expression of TSLP Isoforms in Asthma
Asthma Atopic, Asthma Severe Persistent Uncontrolled
Not yet recruitingPhase 1
Anakinra Rescue Treatment for Moderate Asthma Attacks (ARTMA)
Asthma (Diagnosis), Persistent Asthma
Not yet recruiting
Improving the Quality of Care for Asthma Patients at Risk of Exacerbations
Asthma, Asthma Chronic
RecruitingPhase 2
Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Allergic Asthma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Pascal Piedbois study director
AstraZeneca
724 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Persistent Asthma, run by AstraZeneca at 724 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 724 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To describe the frequency of limitations of activities in patients with persistent asthma depending on gender and age-group. (time frame: Last 3 months / once). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2013.